Your browser doesn't support javascript.
loading
The Authors' Reply to "How to Demonstrate the Impact of Dapagliflozin on Improving Hyperuricemia in Patients with Chronic Kidney Disease".
Mori, Daisuke; Kobayashi, Midori; Wada, Masafumi; Tokuchi, Maho; Misegawa, Soichiro; Saito, Rina; Nomi, Hiroki; Haga, Ryota; Nagatoya, Katsuyuki; Yamauchi, Atsushi.
Afiliação
  • Mori D; Department of Nephrology, Osaka Rosai Hospital, Japan.
  • Kobayashi M; Department of Nephrology, Osaka Rosai Hospital, Japan.
  • Wada M; Department of Nephrology, Osaka Rosai Hospital, Japan.
  • Tokuchi M; Department of Nephrology, Osaka Rosai Hospital, Japan.
  • Misegawa S; Department of Nephrology, Osaka Rosai Hospital, Japan.
  • Saito R; Department of Nephrology, Osaka Rosai Hospital, Japan.
  • Nomi H; Department of Nephrology, Osaka Rosai Hospital, Japan.
  • Haga R; Department of Nephrology, Osaka Rosai Hospital, Japan.
  • Nagatoya K; Department of Nephrology, Osaka Rosai Hospital, Japan.
  • Yamauchi A; Department of Nephrology, Osaka Rosai Hospital, Japan.
Intern Med ; 63(15): 2229-2230, 2024 Aug 01.
Article em En | MEDLINE | ID: mdl-38171866
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article